OTCMKTS:CAPS

Capstone (CAPS) Stock Price, News & Analysis

$5.20
0.00 (0.00%)
(As of 05/3/2024 ET)
Today's Range
$5.20
$5.20
50-Day Range
$5.20
$5.20
52-Week Range
$4.90
$20.00
Volume
1 shs
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
CAPS stock logo

About Capstone Stock (OTCMKTS:CAPS)

Capstone Holding Corp., through its subsidiaries, engages in the distribution of masonry stone products in the United States. Its masonry stone products include manufactured and natural stone cladding products, natural stone landscape products and related goods for residential and commercial construction. The company was formerly known as Capstone Therapeutics Corp. and changed its name to Capstone Holding Corp. in February 2022. Capstone Holding Corp. was incorporated in 1987 and is headquartered in Tempe, Arizona. Capstone Holding Corp. operates as a subsidiary of BP Peptides, LLC.

CAPS Stock Price History

CAPS Stock News Headlines

What Wall Street expects from Capstone Copper's earnings
The asset beating inflation by 4x
"Trump Loophole" Beats Inflation? Inflation has been out of control for years. Forcing you to work longer and harder for more money that is worth less. By using the "Trump Loophole", you can use a special retirement account to buy gold — and other precious metals — without taxes or penalties.
USA Students help shape new park
The asset beating inflation by 4x
"Trump Loophole" Beats Inflation? Inflation has been out of control for years. Forcing you to work longer and harder for more money that is worth less. By using the "Trump Loophole", you can use a special retirement account to buy gold — and other precious metals — without taxes or penalties.
Sabina student helps build underwater robot
See More Headlines
Receive CAPS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Capstone and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
8/13/2018
Today
5/05/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
OTCMKTS:CAPS
Employees
46
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
125.29
5G Stocks: The Path Forward is Profitable Cover

Click the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

Key Executives

  • Mr. Michael M. Toporek III (Age 58)
    CEO, President & Chairman
    Comp: $48k
  • Mr. Edward C. Schultz (Age 39)
    VP, CFO & Treasurer
    Comp: $200k
  • Mr. Matthew E. Lipman (Age 45)
    VP, Secretary & Director
    Comp: $48k

CAPS Stock Analysis - Frequently Asked Questions

How have CAPS shares performed in 2024?

Capstone's stock was trading at $5.20 on January 1st, 2024. Since then, CAPS stock has increased by 0.0% and is now trading at $5.20.
View the best growth stocks for 2024 here
.

How were Capstone's earnings last quarter?

Capstone Holding Corp. (OTCMKTS:CAPS) posted its earnings results on Monday, August, 13th. The biotechnology company reported $0.02 earnings per share (EPS) for the quarter. The biotechnology company had revenue of $2 million for the quarter.

What other stocks do shareholders of Capstone own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Capstone investors own include Fulcrum Therapeutics (FULC), VIVUS (VVUS), Akero Therapeutics (AKRO), CymaBay Therapeutics (CBAY), Cumberland Pharmaceuticals (CPIX), Entasis Therapeutics (ETTX), Evelo Biosciences (EVLO), Kaleido Biosciences (KLDO).

How do I buy shares of Capstone?

Shares of CAPS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:CAPS) was last updated on 5/5/2024 by MarketBeat.com Staff

From Our Partners